UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

Chemical reviews, 1999-09, Vol.99 (9), p.2735-2776

1999

Volltextzugriff (PDF)

Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia

The European journal of neuroscience, 2002-01, Vol.15 (1), p.19-32

2002

Volltextzugriff (PDF)

Expression of specific matrix metalloproteinases in inflammatory myopathies

Brain (London, England : 1878), 2001-02, Vol.124 (2), p.341-351

2001

Volltextzugriff (PDF)

Targeting toll-like receptors for drug development: a summary of commercial approaches

Immunology and cell biology, 2007-08, Vol.85 (6), p.490-494

Gearing, Andrew J H

2007

Volltextzugriff (PDF)

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors

Annals of neurology, 1998-07, Vol.44 (1), p.35-46

1998

Volltextzugriff (PDF)

Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study

Critical care medicine, 1994-04, Vol.22 (4), p.651-657

1994

Volltextzugriff (PDF)

Extracellular matrix-mediated chemotaxis can impede cell migration

Proceedings of the Royal Society. B, Biological sciences, 1998-12, Vol.265 (1413), p.2347-2352

1998

Volltextzugriff (PDF)

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. (Chem. Rev. 1999, 99, 2735−2776. Published on the Web September 8, 1999)

Chemical reviews, 2001-07, Vol.101 (7), p.2205-2206

2001

Volltextzugriff (PDF)

Soluble Forms of Vascular Adhesion Molecules, E-Selectin, ICAM-1, and VCAM-1: Pathological Significance

Annals of the New York Academy of Sciences, 1992-12, Vol.667 (1), p.324-331

1992

Volltextzugriff (PDF)

Differential expression of matrix metalloproteinases in bacterial meningitis

Brain (London, England : 1878), 1999-08, Vol.122 (8), p.1579-1587

1999

Volltextzugriff (PDF)

Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin

Immunology letters, 2002-04, Vol.81 (1), p.41-48

2002

Volltextzugriff (PDF)

DEMONSTRATION OF CYTOKINES IN BIOLOGICAL MEDICINES PRODUCED IN MAMMALIAN CELL LINES

The Lancet (British edition), 1989-10, Vol.334 (8670), p.1011-1012

1989

Volltextzugriff (PDF)

In vivo administration of interleukin 2 stimulates mitosis in thymus and bone marrow

European journal of immunology, 1986, Vol.16 (9), p.1171-1174

1986

Volltextzugriff (PDF)

ChemInform Abstract: Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

ChemInform, 1999-11, Vol.30 (48), p.no-no

1999

Volltextzugriff (PDF)

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis

JAMA neurology, 2021-01, Vol.78 (1), p.102

2021

Volltextzugriff (PDF)

Transethnic genome-wide scan identifies novel Alzheimer's disease loci

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.727-738

2017

Volltextzugriff (PDF)

Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans

JAMA : the journal of the American Medical Association, 2013-04, Vol.309 (14), p.1483

2013

Volltextzugriff (PDF)

Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci

PloS one, 2016-02, Vol.11 (2), p.e0148717-e0148717

2016

Volltextzugriff (PDF)

Assessment of the genetic variance of late-onset Alzheimer's disease

Neurobiology of aging, 2016-05, Vol.41, p.200.e13-200.e20

2016

Volltextzugriff (PDF)

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Nature genetics, 2012-12, Vol.44 (12), p.1349-1354

2012

Volltextzugriff (PDF)

Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals

JAMA neurology, 2015-11, Vol.72 (11), p.1313

2015

Volltextzugriff (PDF)

Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90

Scientific reports, 2022-04, Vol.12 (1), p.6117-6117, Article 6117

2022

Volltextzugriff (PDF)

Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci

Annals of human genetics, 2013-03, Vol.77 (2), p.85-105

2013

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(29)
Humans
(24)
Biological And Medical Sciences
(20)
Animals
(14)
Male
(13)
Female
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Genome-Wide Association Study
(11)
Neurosciences & Neurology
(11)
Medical Sciences
(10)
Alzheimer Disease - Genetics
(9)
Immunology
(9)
Aged
(8)
Clinical Neurology
(8)
Neurology
(8)
Neurosciences
(8)
Alzheimer's Disease
(7)
Biochemistry & Molecular Biology
(6)
Fundamental Immunology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia

Expression of specific matrix metalloproteinases in inflammatory myopathies

Targeting toll-like receptors for drug development: a summary of commercial approaches

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors

Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study

Extracellular matrix-mediated chemotaxis can impede cell migration

Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors. (Chem. Rev. 1999, 99, 2735−2776. Published on the Web September 8, 1999)

Soluble Forms of Vascular Adhesion Molecules, E-Selectin, ICAM-1, and VCAM-1: Pathological Significance

Differential expression of matrix metalloproteinases in bacterial meningitis

Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin

DEMONSTRATION OF CYTOKINES IN BIOLOGICAL MEDICINES PRODUCED IN MAMMALIAN CELL LINES

In vivo administration of interleukin 2 stimulates mitosis in thymus and bone marrow

ChemInform Abstract: Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis

Transethnic genome-wide scan identifies novel Alzheimer's disease loci

Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans

Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

Assessment of the genetic variance of late-onset Alzheimer's disease

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals

Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90

Initial Assessment of the Pathogenic Mechanisms of the Recently Identified Alzheimer Risk Loci

Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes

Suchergebnisse filtern